Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as proportion false recent (PFR), are critical parameters for laboratory-based assays for estimating HIV-1 incidence. Recent review of the data by us and others indicated that MDRI of LAg-Avidity EIA estimated previously required recalibration. We present here results of recalibration efforts using >250 seroconversion panels and multiple statistical methods to ensure accuracy and consensus.A total of 2737 longitudinal specimens collected from 259 seroconverting individuals infected with diverse HIV-1 subtypes were tested with the LAg-Avidity EIA as previously described. Data were analyzed for determination of MDRI at ODn cutoffs of 1.0 to 2.0 using...
Background: The variety and limitations of current laboratory methods for estimating HIV-incidenc...
A limiting antigen avidity enzyme immunoassay (HIV-1 LAg-Avidity assay) was recently developed for c...
OBJECTIVE:HIV seroconversion biomarkers are being used in cross-sectional studies for HIV incidence ...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
Background Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infec-t...
CITATION: Duong, Y. T., et al. 2015. Recalibration of the limiting antigen avidity EIA to determine ...
ArticleBackground: Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1...
Accurate and reliable laboratory methods are needed for estimation of HIV-1 incidence to identify th...
Recent-infection testing assays/algorithms (RITAs) have been developed to exploit the titer and avid...
BACKGROUND: The variety and limitations of current laboratory methods for estimating HIV-incidence h...
BackgroundSerological assays to determine HIV incidence have contributed to estimates of HIV inciden...
<div><p>Background</p><p>Accurate and practical biologic tools to estimate HIV incidence is crucial ...
Detecting recent HIV infections is important to evaluate incidence and monitor epidemic trends. We a...
The application of biomarkers for 'recent' infection in cross-sectional HIV incidence surveillance r...
Background: The variety and limitations of current laboratory methods for estimating HIV-incidenc...
A limiting antigen avidity enzyme immunoassay (HIV-1 LAg-Avidity assay) was recently developed for c...
OBJECTIVE:HIV seroconversion biomarkers are being used in cross-sectional studies for HIV incidence ...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
Background Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infec-t...
CITATION: Duong, Y. T., et al. 2015. Recalibration of the limiting antigen avidity EIA to determine ...
ArticleBackground: Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1...
Accurate and reliable laboratory methods are needed for estimation of HIV-1 incidence to identify th...
Recent-infection testing assays/algorithms (RITAs) have been developed to exploit the titer and avid...
BACKGROUND: The variety and limitations of current laboratory methods for estimating HIV-incidence h...
BackgroundSerological assays to determine HIV incidence have contributed to estimates of HIV inciden...
<div><p>Background</p><p>Accurate and practical biologic tools to estimate HIV incidence is crucial ...
Detecting recent HIV infections is important to evaluate incidence and monitor epidemic trends. We a...
The application of biomarkers for 'recent' infection in cross-sectional HIV incidence surveillance r...
Background: The variety and limitations of current laboratory methods for estimating HIV-incidenc...
A limiting antigen avidity enzyme immunoassay (HIV-1 LAg-Avidity assay) was recently developed for c...
OBJECTIVE:HIV seroconversion biomarkers are being used in cross-sectional studies for HIV incidence ...